• Publications
  • Influence
Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
BACKGROUND Since the discovery of the vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50 (minimum inhibitory concentration [MIC] 8 mg/L), there has been concern about the potential spreadExpand
  • 1,280
  • 76
Spontaneous regression of natural killer cell lymphoma
Spontaneous tumour regression is extremely rare in aggressive lymphoma. A case of natural killer (NK) cell lymphoma with cutaneous manifestation showed an indolent clinical course, and the relapsedExpand
  • 25
  • 1
“Slow VISA,” a Novel Phenotype of Vancomycin Resistance, Found In Vitro in Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Strain Mu3
ABSTRACT Heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) clinical strain Mu3 spontaneously generates VISA strains at an extremely high frequency (≥1 × 10−6). The generated VISAExpand
  • 25
  • 1
  • PDF
T/NK cell type chronic active Epstein–Barr virus disease in adults: an underlying condition for Epstein–Barr virus-associated T/NK-cell lymphoma
A chronic infectious mononucleosis-like illness caused by Epstein–Barr virus (EBV) is called ‘chronic active EBV disease’, which is defined as an EBV-associated lymphoproliferative disease. ThisExpand
  • 36
Combination Effect of Vancomycin and β-Lactams against a Staphylococcusaureus Strain, Mu3, with Heterogeneous Resistance to Vancomycin
ABSTRACT We tested the combined activity of vancomycin and seven β-lactam antibiotics against Staphylococcus aureus clinical strain Mu3, which displays heterogeneous resistance to vancomycin. WhenExpand
  • 38
Chronic myelogenous leukemia with mild basophilia as the predominant manifestation at presentation.
Chronic myelogenous leukemia (CML) is a clonal hematological malignancy typically presenting with basophilia and massive proliferation of differentiating myeloid cells. We report an atypical case ofExpand
  • 13
Successful treatment of extramedullary tumors with low-dose thalidomide in patients with multiple myeloma.
Extramedullary tumor (EMT) is a poor prognostic factor of multiple myeloma (MM). The majority of patients report poor efficacy of thalidomide in MM with EMT, and bortezomib is the preferred choice ofExpand
  • 5
Establishment of a Hairy Cell Leukemia Variant Cell Line, HCLv-07
huge splenomegaly but no superficial lymph node enlargement or hepatomegaly. The white blood cell count was 49.2 ! 10 9 /l with 87.6% abnormal lymphocytes, hemoglobin 13.1 g/dl and a platelet countExpand
  • 4